-
Press ReleaseNew Novartis ESC data highlights strength of cardiovascular portfolio
-
Story
Negative impact of the IRA on patient access to innovative treatments -
Press ReleaseNovartis Entresto receives positive CHMP opinion for pediatric heart failure
-
Story
Bringing Chagas disease to people’s attention -
Story
AI Nurse evolving for heart failure patients in China -
Press ReleaseNovartis receives simultaneous approval for five new products from Japanese Ministry of Health, Labour and Welfare, offering Japanese patients a broad range of novel treatment options
-
Story
Caring for someone with heart failure -
Press ReleaseNovartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran
-
Press ReleaseNovartis completes tender offer for all outstanding shares of The Medicines Company
-
Story
Heart failure is a leading cause of hospitalizations, but it doesn’t have to be -
Story
Living with HFpEF – a patient’s story -
Story
Keeping the heart of patients at the heart of everything we do